Patent Assignment
Reel/Frame 056750/0169
Assignment of Assignor's Interest
Recorded: 2021-06-22
Pages: 41
Assignor
EMISPHERE TECHNOLOGIES, INC.
Executed: 2020-12-08
Assignee
NOVO NORDISK NORTH AMERICA OPERATIONS A/S
NOVO ALLÉ, BAGSVAERD, 2880, DENMARK
Covered Properties
(240)
Modified Amino Acids for Encapsulating Active Agents
Patent:
5,451,410 →
Application:
08/051,019 →
Proteinoid Carriers and Methods for Preparation and Use Thereof
Patent:
5,578,323 →
Application:
08/076,803 →
Desferrioxamine Oral Delivery System
Patent:
5,447,728 →
Application:
08/168,776 →
Oral Drug Delivery Compositions and Methods
Patent:
5,792,451 →
Application:
08/205,511 →
Modified Amino Acids for Drug Delivery
Patent:
5,629,020 →
Application:
08/231,622 →
Acids and Acid Salts and Their Use in Delivery Systems
Patent:
5,541,155 →
Application:
08/231,623 →
Modified Hydrolyzed Vegetable Protein Microspheres and Methods for Preparation and Use Thereof
Patent:
5,540,939 →
Application:
08/233,281 →
Diketopiperazine-Based Delivery Systems
Patent:
5,693,338 →
Application:
08/315,200 →
Active Agent Transport Systems
Patent:
5,714,167 →
Application:
08/328,932 →
Compounds and Compositions for Delivering Active Agents
Patent:
5,643,957 →
Application:
08/335,148 →
Compositions for Oral Delivery of Active Agents
Patent:
5,650,386 →
Application:
08/414,654 →
Microspheres of Diamide-Dicarboxylic Acids
Patent:
5,820,881 →
Application:
08/430,491 →
Proteinoid Microspheres and Methods for Preparation and Use Thereof
Patent:
5,601,846 →
Application:
08/437,698 →
Compositions for the Delivery of Antigens
Patent:
5,958,457 →
Application:
08/438,644 →
Modified Amino Acids for Drug Delivery
Patent:
6,180,140 →
Application:
08/460,265 →
Spray Drying Method and Apparatus
Patent:
5,667,806 →
Application:
08/475,882 →
Proteinoid Emulsions and Methods for Preparation and Use Thereof
Patent:
6,051,258 →
Application:
08/475,885 →
Method of Solubilizing and Encapsulating Itraconazole
Patent:
5,750,147 →
Application:
08/475,887 →
Oral Drug Delivery Compositions and Methods
Patent:
5,766,633 →
Application:
08/537,888 →
Desferrioxamine Oral Delivery System
Patent:
5,811,127 →
Application:
08/635,921 →
Modified Amino Acids for Drug Delivery
Patent:
5,935,601 →
Application:
08/732,404 →
Active Agent Transport Systems
Patent:
6,099,856 →
Application:
08/763,183 →
Compounds and Compositions for Delivering Active Agents
Patent:
5,955,503 →
Application:
08/795,833 →
Compounds and Compositions for Delivering Active Agents
Patent:
6,100,298 →
Application:
08/795,837 →
Compounds and Compositions for Delivering Active Agents
Patent:
5,879,681 →
Application:
08/796,334 →
Compounds and Compositions for Delivering Active Agents
Patent:
5,876,710 →
Application:
08/796,335 →
Compounds and Compositions for Delivering Active Agents
Patent:
6,358,504 →
Application:
08/796,336 →
Compounds and Compositions for Delivering Active Agents
Patent:
5,773,647 →
Application:
08/796,337 →
Compounds and Compositions for Delivering Active Agents
Patent:
5,776,888 →
Application:
08/796,338 →
Compounds and Compositions for Delivering Active Agents
Patent:
5,804,688 →
Application:
08/796,339 →
Compounds and Compositions for Delivering Active Agents
Patent:
5,939,381 →
Application:
08/796,340 →
Compounds and Compositions for Delivering Active Agents
Patent:
6,313,088 →
Application:
08/797,100 →
Compounds and Compositions for Delivering Active Agents
Patent:
6,051,561 →
Application:
08/797,813 →
Compounds and Compositions for Delivering Active Agents
Patent:
6,090,958 →
Application:
08/797,816 →
Compounds and Compositions for Delivering Active Agents
Patent:
6,060,513 →
Application:
08/797,817 →
Compounds and Compositions for Delivering Active Agents
Patent:
5,990,166 →
Application:
08/797,820 →
Compounds and Compositions for Delivering Active Agents
Patent:
5,965,121 →
Application:
08/798,023 →
Compounds and Compositions for Delivering Active Agents
Patent:
6,001,347 →
Application:
08/798,031 →
Compounds and Compositions for Delivering Active Agents
Patent:
5,989,539 →
Application:
08/798,032 →
Compounds and Compositions for Delivering Active Agents
Patent:
5,866,536 →
Application:
08/798,033 →
Compounds and Compositions for Delivering Active Agents
Patent:
6,344,213 →
Application:
08/820,694 →
Modified Amino Acids and Compositions Comprising the Same for Delivering Active Agents
Patent:
6,071,510 →
Application:
08/839,094 →
Diketopiperazine-Based Delivery Systems
Patent:
5,976,569 →
Application:
08/841,101 →
Compounds and Compositions for Delivering Active Agents
Patent:
5,863,944 →
Application:
08/846,254 →
Microencapsulated Fragrances and Method for Preparation
Patent:
6,375,983 →
Application:
08/873,780 →
Method for Preparing - W-Aminoalkanoic Acid Derivatives from Cycloalkanones
Patent:
6,084,112 →
Application:
08/894,490 →
Active Agent Transport Systems
Patent:
6,221,367 →
Application:
08/939,939 →
Oral Delivery Composition Comprising Supramolecula Complex
Patent:
6,071,538 →
Application:
08/940,056 →
Orally Deliverable Supramolecular Complex
Patent:
6,348,207 →
Application:
08/941,609 →
Active Agent Transport Systems
Patent:
6,245,359 →
Application:
08/941,616 →
Method of Solubilizing Itraconazole
Patent:
6,100,285 →
Application:
08/967,486 →
Methods and Compositions for Inducing Oral Tolerance in Mammals
Patent:
6,391,303 →
Application:
09/101,921 →
Proteinoid Carriers and Methods for Preparation and Use Thereof
Patent:
6,413,550 →
Application:
09/197,899 →
Compounds and Compositions for Delivering Active Agents
Method of Solubilizing and Encapsulating Itraconazole
Patent:
6,461,545 →
Application:
09/478,661 →
Compounds and compositions for delivering active agents
Patent:
6,346,242 →
Application:
09/499,958 →
Compounds and compositions for delivering active agents
Patent:
6,242,495 →
Application:
09/596,016 →
Pulmonary Delivery of Active Agents
Patent:
6,440,929 →
Application:
09/744,777 →
Compounds and Compositions for Delivering Active Agents
Patent:
6,642,411 →
Application:
09/744,862 →
Compounds and Compositions for Delivering Active Agents
Patent:
6,991,798 →
Application:
09/762,067 →
Oral Drug Delivery Compositions and Methods
Polymeric Delivery Agents and Delivery Agents Compounds
Patent:
6,627,228 →
Application:
09/889,005 →
Oxadiazole Compounds and Compositions for Delivering Active Agents
Patent:
7,084,279 →
Application:
09/913,049 →
Method of Preparing Alkylated Salicylamides
Compounds and Compositions for Delivering Active Agents
Compounds and Compositions for Delivering Active Agents
Compounds and Compositions for Delivering Active Agents
Compounds and Compositions for Delivering Active Agents
Microencapsulated Fragrances and Method for Preparation
Compounds and Compositions for Delivering Active Agents
Phenyl Amine Carboxylic Acid Compounds and Compositions for Delivering Active Agents
Patent:
7,279,597 →
Application:
10/111,144 →
Phenoxy Carboxylic Acid Compounds and Compositions for Delivering Active Agents
Patent:
7,129,274 →
Application:
10/129,467 →
Liquid heparin formulation
Application:
10/129,940 →
Compounds and Compositions for Delivering Active Agents
Compounds and Compositions for Delivering Active Agents
Pulmonary Delivery of Active Agents
Compounds and Compositions for Delivering Active Agents
Oral Drug Delivery Compositions and Methods
Method of Preparing Alkylated Salicylamides via a Dicarboxylate Intermediate
Active Agent Transport Systems
Method of Preparing Salicylamides
Compounds and Compositions for Delivering Active Agents
Compounds and Compositions for Delivering Active Agents
Compounds and Compositions for Delivering Active Agents
Cyanophenoxy Carboxylic Acid Compounds and Compositions for Delivering Active Agents
(5-(2-Hydroxy-4-Chlorobenzoyl) Aminovaleric Acid and Salts Thereof and Compositions Containing the Same for Delivering Active Agents
Compounds and Compositions for Delivering Active Agents
Compounds and Compositions for Delivering Active Agents
Polymeric Delivery Agents and Delivery Agent Compounds
Compositions for Delivering Bisphosphonates
Compounds and Compositions for Delivering Active Agents
Method of Preparing Phenoxy Alkanoic, Alkenoic, and Alkynoic Acids and Salts Thereof via a Dicarboxylate Intermediate
Phenoxy Amine Compounds and Compositions for Delivering Active Agents
Formulations for oral administration of cromolyn sodium
Application:
10/497,286 →
Publication:
US 2004/0259952
Oral Insulin Therapy
Polymorphs of Sodium 4-[(4-Chloro-2-Hydroxybenzoyl) Amino] Butanoate
Method for administering glp-1 molecules
Application:
10/504,717 →
Publication:
US 2005/0148497
Night-Time Oral Insulin Therapy
Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (MC4) Agonist Peptide
Disodium Salts, Monohydrates, and Ethanol Solvates for Delivering Active Agents
Compounds and Compositions for Delivering Active Agents
Compounds and Compositions for Delivering Active Agents
Compositions for delivering peptide YY and PYY agonists
Application:
10/846,954 →
Publication:
US 2005/0009748
Compounds and compositions for delivering active agents
Application:
11/018,147 →
Publication:
US 2005/0147662
Oral GLP-1 formulations
Application:
11/018,180 →
Publication:
US 2006/0286129
Method of Preparing Alkylated Salicylamides via a Dicarboxylate Intermediate
Compounds and Compositions for Delivering Active Agents
8-(2-Hydroxyphenoxy) Octyldiethanolamine and Salts Thereof for Delivery of Active Agents
Compounds and Compositions for Delivering Active Agents
Application:
11/172,562 →
Publication:
US 2005/0272815
Compounds and Compositions for Delivering Active Agents
Polymorphs of Sodium 4-[(4-Chloro-2-Hydroxybenzoyl) Amino] Butanoate
Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
Application:
11/204,778 →
Publication:
US 2006/0078623
Compounds and Compositions for Delivering Active Agents
Oxadiazole Compounds and Compositions for Delivering Active Agents
Phenoxy Carboxylic Acid Compounds and Compositions for Delivering Active Agents
Cyanophenoxy Carboxylic Acid Compounds and Compositions for Delivering Active Agents
Compounds and Compositions for Delivering Active Agents
Compounds and Compositions for Delivering Active Agents
Solid Dosage Form of Wetted Heparin
Crystalline Polymorphic Forms Of Monosodium N-[-8-(2-Hydroxybenzoyl)Amino]Caprylate
Compositions For Delivering Acyclovir
Application:
11/568,826 →
Publication:
US 2008/0132527
Compounds and Compositions for Delivering Active Agents
Topical Cromolyn Formulations
Compositions for Delivering Peptide Yy and Pyy AG0NISTS
Antidiabetic oral insulin-biguanide combination
Application:
11/632,808 →
Publication:
US 2010/0048454
Polymeric Delivery Agents and Delivery Agent Compounds
Polymorphs of Sodium 4-[(4-Chloro-2-Hydroxybenzoyl) Amino] Butanoate
Pharmaceutical Formulations of Gallium Salts
Polymorphs of Sodium 4-[(4-Chloro-2-Hydroxybenzoyl) Amino] Butanoate
Compositions for Buccal Delivery of Parathyroid Hormone
Gastric Retention and Controlled Release Delivery System
Application:
11/815,234 →
Publication:
US 2008/0153779
Methods for Producing N-(8-[2-Hydroxybenzoyl]-Amino) Caprylic Acid
Human Growth Hormone Formulations
Application:
11/848,034 →
Publication:
US 2008/0095837
Carbon-Substituted Diketopiperazine Delivery Systems
Application:
11/859,506 →
Publication:
US 2008/0008764
Compositions and Methods for Buccal Delivery of Human Growth Hormone
Intraoral Dosage Forms of Glucagon
Aryl Ketone Compounds and Compositions for Delivering Active Agents
Cyclopropyl Compounds and Compositions for Delivering Active Agents
Crystalline Forms of the Di-Sodium Salt of N-(5-Chlorosalicyloyl)-8-Aminocaprylic Acid
Formulations for Oral Administration of Cromolyn Sodium
Disodium Salts, Monohydrates, and Ethanol Solvates for Delivering Active Agents
Orally Dosed Pharmaceutical Compositions Comprising a Delivery Agent in Micronized Form
Phenoxy Carboxylic Acid Compounds and Compositions for Delivering Active Agents
Patent:
7,951,971 →
Application:
12/139,276 →
Amorphous Sodium 4-[4-Chloro-2-Hydroxybenzoyl)Amino]Butanoate
Method of Treating Vitamin B12 Deficiency
Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (MC4) Agonist Peptide
Valacyclovir Formulations
Application:
12/266,510 →
Publication:
US 2009/0124639
Dialkyl Ether Delivery Agents
Formulations for Delivering Insulin
Topical Adminstration of Acyclovir
Gallium Nitrate Formulations
Pharmaceutical Formulations for the Treatment of Alzheimer's Disease
Arylsulfanyl Compounds and Compositions for Delivering Active Agents
Fast Acting Naratriptan Composition
Method for Administering Glp-1 Molecules
Synthesis of Propyl Phenoxy Ethers and Use as Delivery Agents
Application:
12/438,004 →
Publication:
US 2010/0062970
Compounds and Compositions for Delivering Active Agents
Compounds and Compositions for Delivering Active Agents
Oral Insulin Therapies & Protocol
Compositions for Delivering Parathyroid Hormone and Calcitonin
Application:
12/496,317 →
Publication:
US 2009/0264368
Oral GLP-1 Formulations
Solid Pharmaceutical Dosage Forms Comprising Bisphosphonates and Modified Amino Acid Carriers
Acyclovir Formulations
Application:
12/516,798 →
Publication:
US 2010/0069410
Phenylalkylcarboxylic Acid Delivery Agents
Application:
12/522,464 →
Publication:
US 2011/0046050
Compounds Having a Cyclic Moiety and Compositions for Delivering Active Agents
Allyloxy and Alkyloxy Benzoic Acid Delivery Agents
Oral Insulin Therapies and Protocol
Pharmaceutical Formulations Containing Microparticles or Nanoparticles of a Delivery Agent
Application:
12/550,281 →
Publication:
US 2010/0055194
Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp-1) Compound or a Melanocortin-4 Receptor (MC4) Agonist Peptide
Disodium Salts, Monohydrates, and Ethanol Solvates for Delivering Active Agents
Fast-Acting Naproxen Composition with Reduced Gastrointestinal Effects
Application:
12/849,527 →
Publication:
US 2011/0039930
Formulation comprising GLP-1
Oral B12 Therapy
Application:
13/033,118 →
Publication:
US 2011/0207693
Disodium Salts, Monohydrates, and Ethanol Solvates for Delivering Active Agents
Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide
Method of Treating Vitamin B12 Deficiency
Crystalline Forms of the Di-Sodium Salt of N-(5-Chlorosalicyloyl)-8-Aminocaprylic Acid
Fast Acting Naratriptan Composition
Pharmaceutical Formulations Containing Microparticles or Nanoparticles of a Delivery Agent
Application:
13/303,756 →
Publication:
US 2012/0189666
Phenylalkylcarboxylic Acid Delivery Agents
Application:
13/474,491 →
Publication:
US 2012/0258911
Disodium Salts, Monohydrates, and Ethanol Solvates for Delivering Active Agents
Acyclovir Formulations
Application:
13/482,668 →
Publication:
US 2012/0238591
Method of Treating Vitamin B12 Deficiency
Oral Iron Deficiency Therapy
Acyclovir Formulations
Crystalline Forms of the Di-Sodium Salt of N-(5-Chlorosalicyloyl)-8-Aminocaprylic Acid
Method for Treating Bone Related Diseases and Calcium Disorders
Method for Administering Glp-1 Molecules
Application:
13/943,610 →
Publication:
US 2014/0005106
Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp-1) Compound or a Melanocortin-4 Receptor (MC4) Agonist Peptide
Crystalline Polymorphic Forms of Monosodium N-[-8-(2-Hydroxybenzoyl)Amino]Caprylate
Oral Insulin Therapies and Protocol
Phenoxy Alkyl Diethanolamine and Diisopropanolamine Compounds for Delivering Active Agents
Formulations for Delivering Insulin
Application:
14/589,811 →
Publication:
US 2015/0190344
Method for Administering Glp-1 Molecules
Application:
14/603,239 →
Publication:
US 2015/0202296
Oral B12 Therapy
Application:
14/954,393 →
Publication:
US 2016/0074420
Crystalline Polymorphic Forms of Monosodium N-[-8-(2-Hydroxybenzoyl)Amino]Caprylate
Compositions for Delivering Peptide Yy and Pyy Agonists
Application:
15/190,305 →
Publication:
US 2016/0296599
Phenylalkylcarboxylic Acid Delivery Agents
Compounds and Compositions For Delivering Active Agents
Patent:
48,164 →
Application:
15/355,634 →
Antidiabetic Oral Insulin Biguanide Combination
Application:
15/645,851 →
Publication:
US 2018/0161400
Crystalline Polymorphic Forms of Monosodium N-[-8-(2-Hydroxybenzoyl)Amino]Caprylate
Arylsulfanyl Compounds and Compositions for Delivering Active Agents
Application:
15/843,728 →
Publication:
US 2018/0334430
Gastric Retention and Controlled Release Delivery System
Application:
15/845,643 →
Publication:
US 2019/0216729
Formulations for Delivering Insulin
Application:
15/875,397 →
Publication:
US 2018/0338923
Pharmaceutical Formulations Containing Microparticles or Nanoparticles of a Delivery Agent
Application:
15/894,652 →
Publication:
US 2019/0022228
Crystalline Polymorphic Forms of Monosodium N-[-8-(2-Hydroxybenzoyl)Amino]Caprylate
A Process for the Manufacture of Snac (Salcaprozate Sodium)
Phenylalkylcarboxylic Acid Delivery Agents
Oral B12 Therapy
Application:
16/812,888 →
Publication:
US 2020/0206247
Crystalline Polymorphic Forms of Monosodium N-[-8-(2-Hydroxybenzoyl)Amino]Caprylate
Process for the Manufacture of Snac (Salcaprozate Sodium)
Application:
17/101,375 →
Publication:
US 2021/0070691
Practical Synthesis of Omega-Aminoalkanoic Acid Derivatives from Cycloalkanones
Application:
60/003,508 →
Solid Oral Dosage Form Containing Heparin or a Heparinoid in Combination with a Carrier
Application:
60/121,065 →
Liquid Heparin Formulation
Application:
60/165,209 →
Method of Making Alkylated Salicylamides
Application:
60/173,989 →
Ethanol solvate for delivering active agents
Application:
60/186,142 →
(5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
Application:
60/230,332 →
(5-(2-Hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
Application:
60/237,234 →
Method for administering GLP-1 molecules
Application:
60/358,184 →
Compositions for delivering peptide YY and PYY agonists
Application:
60/470,905 →
Compositions for delivering peptide YY and PYY agonists
Application:
60/506,702 →
Oral GLP-1 formulations
Application:
60/530,931 →
Compounds and compositions for delivering active agents
Application:
60/530,941 →
Compositions for delivering peptide YY and PYY agonists
Application:
60/536,697 →
Oral GLP-1 formulations
Application:
60/552,116 →
Compounds and compositions for delivering active agents
Application:
60/552,337 →
Solid dosage form of wetted heparin
Application:
60/569,475 →
Solid dosage form of wetted heparin
Application:
60/572,679 →
Compositions for topical delivery of cromoglycic acid compounds
Application:
60/572,896 →
Compositions for delivering acyclovir
Application:
60/573,003 →
Compositions for delivering peptide YY and PYY agonists
Application:
60/587,751 →
Solid dosage form of heparin
Application:
60/598,978 →
Crystalline polymorphic forms of the di-sodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid
Application:
60/718,829 →
Topical administration of acyclovir
Application:
60/799,294 →
Methods for producing N-(8-[2-hydroxybenzoyl]-amino] caprylic acid
Application:
60/842,775 →
Acyclovir Formulations
Application:
60/868,316 →
Fast-Acting Naproxen Composition with Reduced Gi Effects
Application:
61/230,964 →
Oral B12 Therapy
Application:
61/307,836 →
Oral Iron Deficiency Therapy
Application:
61/353,146 →
Phenoxy Alkyl Diethanolamine and Diisopropanolamine Compounds for Delivering Active Agents
Application:
61/692,554 →
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 24, 1996
From: MILSTEIN, SAM J.; BARANTSEVITCH, EVGUENI N.
To: EMISPHERE TECHNOLOGIES, INC.
Reel/Frame 008171/0710 →
Security Interest
Aug 19, 1996
From: QUANTUM CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 008222/0215 →
Security Agreement
Sep 28, 2005
From: EMISPHERE TECHNOLOGIES, INC.
To: MHR INSTITUTIONAL PARTNERS IIA LP
Reel/Frame 016593/0703 →
Security Agreement
Aug 11, 2006
From: EMISPHERE TECHNOLOGIES, INC.
To: MHR INSTITUTIONAL PARTNERS IIA LP
Reel/Frame 018087/0386 →
Assignment of Assignor's Interest
Mar 5, 2008
From: EMISPHERE TECHNOLOGIES, INC.
To: MANNKIND CORPORATION
Reel/Frame 020599/0179 →
Security Agreement
Jul 3, 2013
From: MANNKIND CORPORATION
To: DEERFIELD PRIVATE DESIGN FUND II, L.P.; DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P.; HORIZON SANTE FLML SARL
Reel/Frame 030740/0123 →
Patent Security Agreement
Sep 26, 2014
From: MANNKIND CORPORATION
To: AVENTISUB LLC
Reel/Frame 033831/0110 →
Release of Security Interest
Nov 10, 2016
From: AVENTISUB LLC
To: MANNKIND CORPORATION
Reel/Frame 040588/0008 →